PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Zebrafish model for an ultra-rare genetic disease identifies potential treatments

XMEA is a recessive, genetic disease that causes progressive muscle weakness.

2025-06-05
(Press-News.org) BIRMINGHAM, Ala. – Can a small fish help identify possible treatments for an ultra-rare inherited disease found in an Alabama boy? The genetic disease is XMEA, which progressively weakens the muscles and can affect the liver and heart. As of March 2024, only 33 cases had ever been seen worldwide.

After the DNA sequence of the boy’s genome showed a mutation in the VMA21 gene, one of the known causes of XMEA, University of Alabama at Birmingham and Children’s of Alabama pediatric neurologist Michael Lopez, M.D., Ph.D., referred the family to the UAB Center for Precision Animal Modeling, or C-PAM.

At C-PAM and in collaboration with a Canadian group, research led by Matthew Alexander, Ph.D., UAB Department of Pediatrics, Division of Pediatric Neurology, and Jim Dowling, M.D., Ph.D., Hospital for Sick Children, Toronto, Ontario, created a preclinical model of XMEA in zebrafish by mutating the fish gene that is analogous to VMA21. While this small, striped fish is commonly found in home aquariums, zebrafish also are a valuable animal model for human disease due to fast growth, large clutch sizes and easy genetic manipulation. They also are transparent as larvae.

In a study published in EMBO Molecular Medicine, Alexander and Dowling now show that their mutant zebrafish have weakened muscles and other symptoms that mirror human XMEA disease. With this simple model, they were able to test 30 clinically tested drugs and identify two that significantly improved XMEA symptoms in the zebrafish. They now are studying the VMA21 mutation in a mammalian model, the mouse, to further push research toward a possible clinical treatment.

“We have established the first preclinical animal model of XMEA, and we have determined that this model faithfully recapitulates most features of the human disease,” Alexander said. “It thus is ideally suited for establishing disease pathomechanisms and identifying therapies.”

Researchers used CRISPR-Cas9, often called molecular scissors for DNA, to create two mutants: a frameshift mutation caused by a one-base pair deletion, and a premature stop codon created during deletion of 14 base pairs and insertion of 21. Both loss-of-function mutations reduced VMA21 protein levels.

Both mutants showed changes consistent with altered muscle structure and function, such as shorter body length and non-inflated swim bladders. They had reduced ability to swim away from a stimulus, and they spent less time swimming and traveled less distance compared to wildtype zebrafish.

The key cellular change in human XMEA is impairment of autophagy, the cell’s recycling system. Autophagy takes place in cell organelles called lysosomes, and these need to be acidic to activate proteases that degrade proteins for recycling into new proteins. Like human XMEA, the mutant fish lysosomes showed a failure to acidify, and the muscle cells had characteristic vacuoles — fluid-filled enclosed structures. Like human XMEA patients, the fish also showed liver and heart pathologies.

Unlike human XMEA, which can vary from mild to moderate symptoms as a progressive disease, the mutant fish showed severe reductions in life span, presumably due to a more complete loss of VMA function compared to human patients.

Since the fish had impaired autophagy and since there are no therapies for XMEA patients, the researchers tested 30 clinically tested autophagy inhibitory compounds from the Selleckchem drug library on the XMEA fish.

Screening of clutches for changed muscle birefringence, a change in the refraction of polarized light that indicates reduced muscle organization, the team identified nine compounds that both reduced abnormal birefringence and prolonged fish survival. Long-term testing of the nine for improvements in survival and swimming showed that edaravone and LY294002 had the greatest therapeutic effects.

“Excitingly, we found that several autophagy antagonists could ameliorate aspects of the VMA21 zebrafish phenotype, and two compounds in particular improved the phenotype across multiple domains of birefringence, motor function and survival,” Alexander said. “The fact that multiple autophagy modulators ameliorated aspects of the phenotype supports an important role for autophagy in the disease process and lends confidence to the validity and potential translatability of the findings to patients.”

Co-authors with Alexander and Dowling in the study “X-linked myopathy with excessive autophagy: characterization and therapy testing in a zebrafish model,” are Lily Huang, Rebecca Simonian and Lacramioara Fabian, Hospital for Sick Children; and Michael A. Lopez, Muthukumar Karuppasamy, Veronica M. Sanders and Katherine G. English, UAB Department of Pediatrics, Division of Pediatric Neurology.

At UAB, Pediatrics is a department in the Marnix E. Heersink School of Medicine.

XMEA stands for X-linked myopathy with excessive autophagy.

END


ELSE PRESS RELEASES FROM THIS DATE:

Masking, distancing and quarantines keep chimps safe from human disease, study shows

2025-06-05
Long before COVID-19 forced most of the world behind masks and into isolation, viral diseases had been persistently jumping from humans to primate species, with drastic consequences. The problem became particularly stark on Dec. 31, 2016, when a viral outbreak was detected at a field site for research on chimpanzees, called Ngogo, in Uganda's Kibale National Park. The outbreak, from a virus that originated in humans, ultimately killed 25 of the nearly 200 Ngogo chimps, which researchers have studied for 30 years. A new study led by a University of Arizona primatologist, published in the journal Biological Conservation, provides ...

Dr. Warren Johnson honored with Weill Award

2025-06-05
Dr. Warren Johnson, a professor emeritus of medicine and founding director of Weill Cornell Medicine’s Center for Global Health, has been awarded the institution’s Joan and Sanford I. Weill Exemplary Achievement Award. Weill Cornell Medicine established the Weill Award in 2018 in honor of the institution’s preeminent benefactors, Joan and Sanford I. Weill, and to celebrate the 20th anniversary of the institution’s renaming. The award, which carries a $50,000 cash prize, is presented to an exceptional faculty member whose transformational work enhances health care ...

Adopting a healthy diet may have cardiometabolic benefits regardless of weight loss

2025-06-05
Embargoed for release: Thursday, June 5, 4:00 PM ET Key points: Nearly one-third of nutrition clinical trial participants who adopted and adhered to a healthy diet did not lose any weight, but still saw significant improvements to their cardiometabolic health, including higher HDL cholesterol, lower levels of leptin, and less visceral fat. The findings demonstrate that individuals resistant to weight loss may still achieve meaningful health benefits with lifestyle changes. Cutting-edge omics tools revealed 12 specific DNA methylation sites that strongly predict long-term weight loss—a novel finding that shows how some people may be ...

New study reveals global warming accelerates antibiotic resistance in soils

2025-06-05
A new international study involving researchers from Durham University has revealed that climate change is accelerating the rate of development and global abundances of antibiotic resistance bacteria in soils.   The findings, published in the journal Nature Ecology & Evolution, highlight a new and deeply concerning less seen consequence of global warming to public health.   The study shows that rising global temperatures are significantly increasing the abundance of antibiotic resistance genes (ARGs) and virulence factors in soil microbial ...

Scientists argue for more FDA oversight of healthcare AI tools

2025-06-05
An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Medicine by Leo Celi of the Massachusetts Institute of Technology, and colleagues.  Artificial intelligence is becoming a powerful force in healthcare, helping doctors diagnose diseases, monitor patients, and even recommend treatments. Unlike traditional medical devices, many AI tools continue ...

Study finds dehorning of rhinos drastically reduces poaching

2025-06-05
EMBARGOED UNTIL Thursday, 5 June 2025 at 14:00 (2:00 pm) U.S. Eastern Time (8pm South Africa time, 7pm UK time) JOINT MEDIA RELEASE Study finds dehorning of rhinos drastically reduces poaching More rhino images and video clips available via the link below An international study published today (5 June 2025) in the prestigious journal Science found that dehorning rhinos resulted in a drastic reduction in poaching of these endangered animals. This is based on the analysis of data across 11 reserves in the Greater Kruger region of South Africa between 2017 and 2023. Poaching for their horn is a major threat to the world’s five rhino species. The project was a collaboration ...

NIH researchers conclude that taurine is unlikely to be a good aging biomarker

2025-06-05
Scientists at the National Institutes of Health (NIH) have found that levels of circulating taurine, a conditionally essential amino acid involved in multiple important biological functions, is unlikely to serve as a good biomarker for the aging process. In blood samples from humans, monkeys, and mice, scientists found that circulating taurine levels often increased or remained constant with age. Analysis of longitudinal data showed that within individual differences in taurine levels often exceeded age-related changes. Researchers also found that taurine levels were inconsistently associated with ...

Caterpillar factories produce fluorescent nanocarbons

2025-06-05
Researchers led by Kenichiro Itami at the RIKEN Pioneering Research Institute (PRI) / RIKEN Center for Sustainable Resource Science (CSRS) have successfully used insects as mini molecule-making factories, marking a breakthrough in chemical engineering. Referred to as “in-insect synthesis,” this technique offers a new way to create and modify complex molecules, which will generate new opportunities for the discovery, development, and application of non-natural molecules, such as nanocarbons. Molecular nanocarbons are super tiny structures made entirely of carbon atoms. Despite their minuscule size, they can be ...

Taurine is not a reliable biomarker for aging, longitudinal study shows

2025-06-05
Research in animals and humans has suggested low levels of taurine may be a driver for aging, which has led to discussions about whether taurine is an aging biomarker. Now, a comprehensive study involving longitudinal data from humans, monkeys, and mice shows that taurine levels in the blood do not consistently decline with age, and that levels of taurine vary more by factors unique to each individual than based on aging. These results lead the study authors – Maria Fernandez and colleagues – to conclude that “the efficacy of taurine supplementation to delay aging ...

Lidar survey reveals expansive precolonial maize farming in Michigan’s Upper Peninsula

2025-06-05
Findings from a new archaeological survey challenge long-held assumptions that intensive agriculture in North America was limited to centralized societies or favorable environments. The findings reveal an extensive precolonial agricultural landscape in Michigan’s Upper Peninsula, suggesting Indigenous American communities cultivated maize intensively between 1000 and 1600 CE, despite a cold climate and marginal growing conditions. Indigenous American communities across what is now the United States increasingly relied on intensive maize cultivation, ...

LAST 30 PRESS RELEASES:

Capturability distinction analysis of continuous and pulsed guidance laws

CHEST expands Bridging Specialties Initiative to include NTM disease and bronchiectasis on World Bronchiectasis Day

Exposure to air pollution may cause heart damage

SwRI, UTSA selected by NASA to test electrolyzer technology aboard parabolic flight

Prebiotics might be a factor in preventing or treating issues caused by low brain GABA

Youngest in class at higher risk of mental health problems

American Heart Association announces new volunteer leaders for 2025-26

Gut microbiota analysis can help catch gestational diabetes

FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship

Champions for change – Paid time off initiative just made clinical trials participation easier

Fentanyl detection through packaging

Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics

New 3D glacier visualizations provide insights into a hotter Earth

Creativity across disciplines

Consequences of low Antarctic sea ice

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

Fat may play an important role in brain metabolism

New study finds no lasting impact of pandemic pet ownership on human well-being

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Gut microbes could protect us from toxic ‘forever chemicals’

Novel modelling links sea ice loss to Antarctic ice shelf calving events

Scientists can tell how fast you're aging from a single brain scan

U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050

Public take the lead in discovery of new exploding star

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

[Press-News.org] Zebrafish model for an ultra-rare genetic disease identifies potential treatments
XMEA is a recessive, genetic disease that causes progressive muscle weakness.